High rates of injection drug use in urban Aboriginal youth signal need for prevention programs

June 13, 2011

A new study indicates high rates of injection drug use in urban Canadian Aboriginal youth, particularly in women, and points to the need for culturally specific prevention programs, states an article in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj101257.pdf

Aboriginal leadership is alarmed at the levels of substance abuse in their young people, especially injection drug use, which is associated with HIV and hepatitis C virus infections. Injection drug use accounts for 70%󈞼% of all hepatitis C virus and almost 60% of HIV infections in Aboriginal youth under age 24 in Canada. The history of colonization, including the effect of residential schooling on several generations and the child welfare system, has had significant negative effects on Aboriginal communities. Many children and youth have experienced physical, sexual and emotional abuses as well as exposure to familial violence and drug dependence.

The Cedar Project is a prospective study of 605 Aboriginal youth in Vancouver and Prince George, British Columbia, conducted from 2003 to 2007 that sought to understand use of illicit drugs, particularly relating to infection with HIV. Participants were between the ages of 14 and 30 years and had smoked or injected illicit drugs, other than marijuana, in the month before enrolment. The median age was 23, and 292 (48.3%) were women.

At the start of the study, 335 (55.4%) of participants reported a history of injection drug use. Injection drug users were more likely to be women, to be older, to identify as gay, lesbian, bisexual or two-spirited, to have experienced sexual abuse, to have a parent who attended a residential school and to have other risk factors. In participants who had no history of injection drug use and who attended at least one follow-up visit (197 out of 270), 39 people (18 men, 21 women) began to inject drugs.

Young Aboriginal women were twice as likely to inject drugs as men.

"In our study population, about 11 participants per 100 person-years will transition to injection drug use -- a rate that is almost twice as high as that found in the only other available longitudinal study done in Canada investigating transition to injection drug use among young people (6.8 per 100 person-years in Montréal, Quebec)," states Dr. Patricia Spittal, School of Population and Public Health, University of British Columbia, with coauthors. "Transition to injection drug use at a young age not only increases the risk of contracting an infectious disease, it also further entrenches the young person in an increasingly dangerous street life that often involves sex work, violence, predation and life-long addiction."

The study was conducted by researchers from the School of Population and Public Health, University of British Columbia; Simon Fraser University; the Centre for Health Evaluation and Outcome Sciences at Providence Health Care; the Wuikinuxv Nation, Port Hardy, BC; and the Splats'in/Secwepemc Nation, Enderby, BC.

"This study documents an unacceptable number of young, at-risk Aboriginal people transitioning to injection drug use every year; however, there are no prevention programs tailored specifically to this population," states Chief Wayne Christian and coauthors. "Support for community-based programs that address the potential for drug dependence within the context of sexual trauma should be prioritized to respond to the dual epidemics of injection drug use and blood-borne infection among Aboriginal people," they conclude.
-end-


Canadian Medical Association Journal

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.